BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24411580)

  • 1. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation.
    Hu SC; Lin CL; Hong CH; Yu HS; Chen GS; Lee CH
    J Dermatol Sci; 2014 Apr; 74(1):31-8. PubMed ID: 24411580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL21 Induces mTOR-dependent MALAT1 Expression, Leading to Cell Migration in Cutaneous T-Cell Lymphoma.
    Hong CH; Lin SH; Lee CH
    In Vivo; 2019; 33(3):793-800. PubMed ID: 31028199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides.
    Levidou G; Siakantaris M; Papadaki T; Papadavid E; Vassilakopoulos TP; Angelopoulou MK; Marinos L; Nikolaou V; Economidi A; Antoniou C; Patsouris E; Korkolopoulou P
    J Am Acad Dermatol; 2013 Sep; 69(3):375-84. PubMed ID: 23685026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray analysis of gene expression by microdissected epidermis and dermis in mycosis fungoides and adult T-cell leukemia/lymphoma.
    Hashikawa K; Yasumoto S; Nakashima K; Arakawa F; Kiyasu J; Kimura Y; Saruta H; Nakama T; Yasuda K; Tashiro K; Kuhara S; Hashimoto T; Ohshima K
    Int J Oncol; 2014 Sep; 45(3):1200-8. PubMed ID: 24970722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
    Mehdi SJ; Moerman-Herzog A; Wong HK
    BMC Cancer; 2021 May; 21(1):492. PubMed ID: 33941102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD31 in Mycosis Fungoides.
    Jankowska-Konsur A; Kobierzycki C; Grzegrzolka J; Piotrowska A; Gomulkiewicz A; Glatzel-Plucinska N; Olbromski M; Podhorska-Okolow M; Szepietowski JC; Dziegiel P
    Anticancer Res; 2016 Sep; 36(9):4575-82. PubMed ID: 27630298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides.
    Daggett RN; Kurata M; Abe S; Onishi I; Miura K; Sawada Y; Tanizawa T; Kitagawa M
    Br J Dermatol; 2014 Oct; 171(4):722-31. PubMed ID: 24725174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Associated Fibroblasts in Mycosis Fungoides Promote Tumor Cell Migration and Drug Resistance through CXCL12/CXCR4.
    Aronovich A; Moyal L; Gorovitz B; Amitay-Laish I; Naveh HP; Forer Y; Maron L; Knaneh J; Ad-El D; Yaacobi D; Barel E; Erez N; Hodak E
    J Invest Dermatol; 2021 Mar; 141(3):619-627.e2. PubMed ID: 32795528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of hypoxia-inducible factor 1 alpha impacts FoxP3 levels in mycosis fungoides--cutaneous T-cell lymphoma: clinical implications.
    Alcántara-Hernández M; Torres-Zárate C; Pérez-Montesinos G; Jurado-Santacruz F; Domínguez-Gómez MA; Peniche-Castellanos A; Ferat-Osorio E; Neri N; Nambo MJ; Alvarado-Cabrero I; Moreno-Lafont M; Huerta-Yepez S; Bonifaz LC
    Int J Cancer; 2014 May; 134(9):2136-45. PubMed ID: 24127318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay.
    Yagi H; Seo N; Ohshima A; Itoh T; Itoh N; Horibe T; Yoshinari Y; Takigawa M; Hashizume H
    Am J Surg Pathol; 2006 Sep; 30(9):1111-9. PubMed ID: 16931956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of CXCR3 and CD30 in mycosis fungoides.
    Nikoo A
    Arch Iran Med; 2012 Mar; 15(3):146-50. PubMed ID: 22369302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-155 is involved in tumor progression of mycosis fungoides.
    Moyal L; Barzilai A; Gorovitz B; Hirshberg A; Amariglio N; Jacob-Hirsch J; Maron L; Feinmesser M; Hodak E
    Exp Dermatol; 2013 Jun; 22(6):431-3. PubMed ID: 23711069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of the expression of matrix metalloproteinase-9 in skin lesions of mycosis fungoides.
    Rasheed H; Tolba Fawzi MM; Abdel-Halim MR; Eissa AM; Mohammed Salem N; Mahfouz S
    Am J Dermatopathol; 2010 Apr; 32(2):162-9. PubMed ID: 20051814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides.
    Kallinich T; Muche JM; Qin S; Sterry W; Audring H; Kroczek RA
    J Invest Dermatol; 2003 Nov; 121(5):1045-52. PubMed ID: 14708605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.
    Kakinuma T; Sugaya M; Nakamura K; Kaneko F; Wakugawa M; Matsushima K; Tamaki K
    J Am Acad Dermatol; 2003 Jan; 48(1):23-30. PubMed ID: 12522366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
    Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
    Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparison of expression of cutaneous lymphocyte-associated antigen (CLA), and Th1- and Th2-associated antigens in mycosis fungoides and cutaneous lesions of adult T-cell leukemia/lymphoma.
    Yamaguchi T; Ohshima K; Tsuchiya T; Suehuji H; Karube K; Nakayama J; Suzumiya J; Yoshino T; Kikuchi M
    Eur J Dermatol; 2003; 13(6):553-9. PubMed ID: 14721775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.